Cargando…
The Nek2 centrosome-mitotic kinase contributes to the mesenchymal state, cell invasion, and migration of triple-negative breast cancer cells
Nek2 (NIMA‐related kinase 2) is a serine/threonine-protein kinase that localizes to centrosomes and kinetochores, controlling centrosome separation, chromosome attachments to kinetochores, and the spindle assembly checkpoint. These processes prevent centrosome amplification (CA), mitotic dysfunction...
Autores principales: | Rivera-Rivera, Yainyrette, Marina, Mihaela, Jusino, Shirley, Lee, Miyoung, Velázquez, Jaleisha Vélez, Chardón-Colón, Camille, Vargas, Geraldine, Padmanabhan, Jaya, Chellappan, Srikumar P., Saavedra, Harold I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079711/ https://www.ncbi.nlm.nih.gov/pubmed/33907253 http://dx.doi.org/10.1038/s41598-021-88512-0 |
Ejemplares similares
-
Ethnic and racial-specific differences in levels of centrosome-associated mitotic kinases, proliferative and epithelial-to-mesenchymal markers in breast cancers
por: Rivera-Rivera, Yainyrette, et al.
Publicado: (2022) -
Centrosome – a promising anti-cancer target
por: Rivera-Rivera, Yainyrette, et al.
Publicado: (2016) -
Sustained Shugoshin 1 downregulation reduces tumor growth and metastasis in a mouse xenograft tumor model of triple-negative breast cancer
por: Jusino, Shirley, et al.
Publicado: (2023) -
The E2F activators control multiple mitotic regulators and maintain genomic integrity through Sgo1 and BubR1
por: Lee, Miyoung, et al.
Publicado: (2017) -
Centrosome aberrations and chromosome instability contribute to tumorigenesis and intra-tumor heterogeneity
por: Jusino, Shirley, et al.
Publicado: (2018)